Is CYT or DGRO a better dividend investment in 2026?

CYT currently yields 66.23% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: CYT offers higher current income.

What is the dividend yield difference between CYT and DGRO?

CYT has a forward dividend yield of 66.23% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 64.10 percentage points.

Home › Compare › CYT vs DGRO

CYT vs DGRO: Dividend Comparison 2026

CYT yields 66.23% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CYT wins by $848.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CYT

● Live price

66.23%

Share price

$3.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$880.0K

Annual income

$221,634.45

Full CYT calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — CYT vs DGRO

📍 CYT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CYT	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CYT + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CYT pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYT

Annual income on $10K today (after 15% tax)

$5,629.14/yr

After 10yr DRIP, annual income (after tax)

$188,389.28/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, CYT beats the other by $188,185.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYT + DGRO for your $10,000?

CYT: 50%DGRO: 50%

100% DGRO50/50100% CYT

Portfolio after 10yr

$455.8K

Annual income

$110,937.20/yr

Blended yield

24.34%

📊

Analyst Conviction Gap

Where Wall Street is split right now

CYT

No analyst data

Price Target

$2.00

-33.8% upside vs current

Range: $2.00 — $2.00

Altman Z

9.4

Piotroski

1/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYT buys

DGRO buys

No recent congressional trades found for CYT or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCYTDGRO

Forward yield	66.23% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$880.0K ✓	$31.6K
Annual income after 10y	$221,634.45 ✓	$239.96
Total dividends collected	$742.8K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CYT vs DGRO ($10,000, DRIP)

Year	CYT Portfolio	CYT Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$17,323	$6,622.52	$11,293	$213.22	+$6.0K → CYT
2	$29,256	$10,721.37	$12,730	$217.32	+$16.5K → CYT
3	$48,227	$16,923.00	$14,326	$221.10	+$33.9K → CYT
4	$77,675	$26,071.48	$16,098	$224.56	+$61.6K → CYT
5	$122,356	$39,243.54	$18,064	$227.74	+$104.3K → CYT
6	$188,694	$57,773.40	$20,246	$230.65	+$168.4K → CYT
7	$285,170	$83,268.01	$22,666	$233.30	+$262.5K → CYT
8	$422,742	$117,609.16	$25,349	$235.73	+$397.4K → CYT
9	$615,273	$162,940.02	$28,325	$237.94	+$586.9K → CYT
10	$879,977	$221,634.45	$31,624	$239.96	+$848.4K → CYT

CYT vs DGRO: Complete Analysis 2026

CYT — Stock

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.

Full CYT Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this CYT vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYT vs SCHD CYT vs JEPI CYT vs O CYT vs KO CYT vs MAIN CYT vs VIG CYT vs NOBL CYT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.